ScholarWorks@Korea University College of Medicine: Kim, Chul Yong

Detailed Information

Kim, Chul Yong (김철용)

Anam Hospital (Department of Radiation Oncology, Anam Hospital)

Research Area

Tel
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

Radiotherapy:16||Radiation therapy:8||radiotherapy:7||방사선치료:7||Breast cancer:4||Hepatocellular carcinoma:3||Spectrophotometer:3||Korea:3||hepatocellular carcinoma:3||Dosimetrical index:3||Tomotherapy:3||Complications:2||Risk factors:2||Utilization:2||Biological index:2||Prostate cancer:2||PRESAGE (TM) gel dosimeter:2||Lung cancer:2||IntensityModulated Radiation Therapy:2||예후인자:2||Gel dosimeter:2||Nasopharyngeal carcinoma:2||자궁경부암:2||Radiation pneumonitis:2||Adjuvant chemotherapy:2||체표면 움직임:2||Radiological properties:2||Anthracycline:2||Stereotactic body radiotherapy:2||Toxicity:2||Rectal cancer:2||Magnetic resonance imaging:2||TLD:2||Threedimensional dosimetry:2||Normoxic polymer gel:2||Optical CT scanner:2||radiation therapy:2||Elderly:2||Treatment outcome:2||Optimization:2||방사선조사:2||rectal cancer:2||Respiration gating radiotherapy technique:2||Imageguided radiotherapy:2||Body surface motion:2||DCAR:1||Deformable Registration:1||Department ofNeurosurgery:1||Docetaxel:1||Dose Distribution:1||Dose linearity:1||Dose response:1||Doseresponse relationship:1||Dosevolume histogram:1||Dosimetric accuracy:1||Dosimetric characteristics:1||Dosimetric index:1||ERCC1:1||Electrometer:1||Electron beam radiotherapy:1||Electronic portal image:1||Eleutherococcus senticosus:1||Epithelium:1||Esophagitis:1||Extranodal NK/Tcell lymphoma:1||Extremity:1||Film dosimetry:1||Fraction size:1||Gallbladder cancer:1||Gender:1||Glands:1||HDR Brachytherapy:1||HER2:1||Halcyon (TM):1||Head and neck neoplasms:1||Hepatocellular Carcinoma:1||High dose rate brachytherapy:1||High grade glioma:1||Highdoserate brachytherapy:1||IMRT:1||IORT:1||IORT (intraoperative radiation therapy):1||Imageguided radiation therapy:1||Immobilization:1||Immunity:1||Inferior vena cava:1||Intensity modulated radiation therapy (IMRT):1||Intensitymodulated radiation therapy:1||Intraluminal brachytherapy:1||Intraoperative radiation therapy:1||Ionization chamber:1||Keloids:1||Korea University:1||Lamina propria:1||Laryngeal neoplasms·Radiotherapy·Recurrence·Salvage therapy·Laryngectomy.:1||Life expectancy:1||Local control:1||Locoregional control:1||Lung cancer Radiotherapy:1||M.D.:1||MFA:1||MRI:1||MVCT:1||Magnetic resonance images:1||Maxillary sinus:1||Meningioma:1||Metaanalysis:1||Metaruleguided mining:1||Monte Carlo algorithm:1||Moving phantom:1||Multicenter study:1||Myelodysplastic syndrome:1||NK/T cell:1||Nasal type:1||Nimodopine:1||Nonscattering gel:1||Nonsmallcell lung cancer:1||Normal tissue complication probability:1||Onboard imager:1||Optical scanner:1||Optimal wavelength:1||Organ movement:1||Organs at risk:1||Output factor:1||PIK3CA:1||PLD:1||Pancreatic cancer:1||Pap smear:1||Papillary thyroid carcinoma:1||Patient motion:1||Patient’ body movement:1||Patterns of care study:1||Pelvic neoplasms:1||Performance:1||Pituitary adenoma:1||Plan optimization:1||Polymer gel:1||Portal vein:1||Portal vein thrombosis:1||Postoperative:1||Preoperative chemoradiotherapy:1||Proctitis:1||Prognosis:1||Prognostic factor:1||Prognostic factors:1||Quality control:1||Quality factor:1||RASSF1A:1||RRSS (Realtime respiratory simulation system):1||Radiation Apoptosis Nimodipine Spinal cord Rat.Laboratory InvestigationReceived ：June 24:1||Radiation protection:1||Radiobiological index:1||Radiochromic gel:1||Radiotherapy dosage:1||Reirradiation:1||Rectal neoplasms:1||Rectum:1||Recurrence:1||Respiration:1||Respiration gating radiation therapy technique:1||Retrospective analysis:1||Right atrium:1||Risk factor:1||Robotic couch:1||S:1||SCC antigen:1||Salmonella Typhimurium:1||Sarcoma:1||Scan image control:1||School of Medicine:1||Second primary cancer:1||Secondary biliary tumor:1||Selective internal radiotherapy:1||Sensor:1||Sensor based computercontrolled motion phantom (SBMP):1||Sensors:1||Setup error:1||Small field:1||Squamous cell carcinoma of the head and neck:1||Surgery:1||Survival:1||Synchrony:1||Toxicity prediction:1||Tracking:1||Trastuzumab:1||Treatment plan parameters:1||Treatment planning decision support system:1||Triphala:1||Tumor tracking:1||Ultra sonic sensor:1||Uterine cervical cancer:1||Validation:1||Variable importance:1||Virtual organ delineation (VOD):1||VitalBeam (R):1||Xirradiation:1||X선 조사:1||Zebrafish:1||bacterial treatment:1||brachytherapy:1||breast cancer:1||breast reconstruction:1||breathing movement:1||cancer:1||carcinoma of the uterine cervix:1||central tumor:1||chemotherapy:1||consistency:1||couch:1||delay time:1||diode detector:1||doseR2 response curve:1||dosevolume histogram (DVH):1||dosimetric comparison:1||endobronchial brachytherapy:1||experimental:1||external beam radiotherapy:1||extranodal lymphoma:1||feasibility:1||fibroblast growth factor 2:1||fractionated stereotactic radiotherapy:1||high dose rate:1||highdose:1||imageguided radiation therapy (IGRT):1||intensitymodulated radiation therapy:1||interfractional variation:1||interruption:1||intracavitary brachytherapy:1||leftsided breast cancer:1||locoregional control:1||lung cancer:1||lymph node metastasis:1||melanoma:1||meningioma:1||metaanalysis:1||mistletoe:1||moving tumor:1||multipurpose brachytherapy phantom (MPBP):1||nonsmall cell lung cancer:1||normoxic polymer gel:1||oleate:1||onboard imagers:1||organ at risk:1||papillary thyroid carcinoma:1||pathologic tumor regression grade:1||pelvic irradiation:1||phospholipase D:1||portal vein thrombosis:1||predictive modelling:1||preoperative concurrent chemoradiotherapy:1||preoperative radiotherapy:1||prostate cancer:1||radiation injuries:1||radiation treatment planning (RTP) system:1||radiation treatment planning decision support program (PDSS):1||radioprotectant:1||radiotherapy, computerassisted:1||rectal dose:1||rectal retractor:1||residual tumor volume:1||respirationmonitoring mask (ReMM):1||respiratory motion:1||respiratory motion reduction device system (RMRDs):1||rspiratorygated radiation therapy (RGRT):1||setup reproducibility:1||survival:1||target volume:1||thermocouple:1||threedimensional dosimeter:1||tomotherapy:1||toxicity:1||tracking:1||treatment plan:1||treatment response:1||ultracentral tumor:1||vascular endothelial growth factor a:1||vascular neoplasms:1||virtual organ delineation:1||가시오갈피:1||갑상선 유두암:1||고령:1||고선량율 관내 근접치료:1||고선량율 근접치료:1||고악성도 신경아교종:1||골반경:1||공기동:1||뇌조직 손상:1||뇌종양:1||독성:1||동 팬텀:1||동시항암화학방사선치료:1||듀로제식:1||림프절절제술:1||면역:1||방사선 화학 동시요법:1||방사선량 측정장비:1||방사선치료로 인한 통증:1||병용요법:1||부작용:1||부친암:1||비소세포폐암:1||상악동 편평세포암:1||세포독성:1||센서:1||속발성 담도종양:1||수막종:1||수술 중 방사선 치료:1||수술중 방사선치료:1||수술중방사선치료:1||암성통증:1||임동준:1||입체조형 동적회전조사 방사선치료:1||자멸사:1||전신방사선조사:1||정도관리:1||직장암:1||초음파센서:1||최적화:1||췌장암:1||치료테이블에 기반한 동 팬텀(CBMP):1||코인두암:1||폐암:1||필름 선량계:1||허용 기준:1||호흡운동 조절 방사선치료:1||호흡운동조절 방사선치료 기술:1||후두모형:1||(DRESS)DP:1||흡수선량:1||1261:1||2003 Accepted ：July 15:1||2003Address for reprints ：Yong Gu Chung:1||2D and 3D margin:1||3D QA:1||3D dose analysis:1||3D dose evaluation program:1||3D optical scanner (P3DS):1||4D radiotherapy:1||4dimesional computed tomography (4DCT):1||9205326:1||Absorbance:1||Acceptable criteria:1||Acute myeloid leukaemia:1||Anam dong 5 ga:1||Artificial neural network:1||Automatic registration control:1||BANGkit (TM) gel dosimeter:1||Biliary obstruction:1||Bladder:1||Body mass index:1||Brain tumor:1||Breast neoplasms:1||Breast size:1||Bronchogenic Carcinoma:1||CEA:1||Cancer:1||Cervical cancer:1||Chemoradiotherapy:1||Chest xray:1||Circumferential resection margin:1||Cisplatin:1||Colorectal neoplasms:1||Combined modality therapy:1||Complication:1||Composition ratio:1||Concomitant chemoradiation:1||Concurrent chemoradiation therapy:1||Conebeam computed tomography:1||Congestive heart failure:1||Couch based computercontrolled motion phantom (CBMP):1||Cranial irradiation· Radiation injuries· Apoptosis· Rat.:1||CyberKnife:1||Cytotoxicity:1||

STATISTICS: Total View :12,802,988; Today View :11,843

RSS_1.0 RSS_2.0 ATOM_1.0

73, Goryeodae-ro, Seongbuk-gu, Seoul, Republic of Korea (02841)82-2-2286-1265

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE